NOVATO, Calif. - Ultragenyx Pharmaceutical Inc. (NASDAQ: NASDAQ:RARE), a $4.08 billion market cap biotechnology company with 27% revenue growth in the past year, today unveiled new data indicating ...
Cristina Brennan can hear the clock ticking. At the end of the year, her 12-year-old son Tristan will no longer have free ...
Despite the gruelling treatments, Khaled refused to lose hope and drew strength from his faith and the unwavering support of friends, fellow survivors ...
Christian Fellowship Center Lead Pastor Brian Dube is making a miraculous recovery from a case of near-fatal paralysis from a ...
Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice. The novel drug CT-179 was ...
A research team has identified a critical event driving tumor growth in a type of medulloblastoma -- and a way to block it.
A TEEN who’s been diagnosed with melanoma twice and had two brain tumours removed, all before the age of 18, has a rare ...
Ruby-Jo Sneed, 18, was diagnosed with a rare genetic chromosome deletion after undergoing genetic testing aged 12 due to her ...
This was highlighted by Dr Sermed Mezher in a recent reel posted on Instagram, “People with KLS experience recurring episodes where they sleep excessively, sometimes up to 20 hours a day, for weeks at ...
For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that ...
In the United States, nearly three million adults 18 years and older reported having active epilepsy during 2021 and 2022.